companiesandmarkets.com

Return to Report | Print

Alkermes Inc - Premium Company Profile

http://www.companiesandmarkets.com/Summary-Company-Profile/alkermes-inc-premium-company-profile-41232.asp

Report Summary

Introduction

Alkermes is a biotechnology company focused on drug development process from a patient-centric perspective, beginning with a thorough understanding of the challenges patients face on a day-to-day basis. The company's acquisition of Medisorb Technologies and Advanced Inhalation Research (AIR) in 1996 and 1996 have resulted Alkermes in emerging as strong player with proven proprietary technologies.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    Alkermes develops innovative medicines based on sophisticated drug delivery technologies to enhance therapeutic outcomes in major diseases and improve patient's lives.

    The company has two commercial products: Risperdal Consta (risperidone), a long-acting atypical antipsychotic medication for schizophrenia and Vivitrol (naltrexone for extended-release injectable suspension), the first and only once-monthly injectable medication for the treatment of alcohol dependence

    Its product candidates include ALKS 29 for alcohol dependence, AIR Inhaled Insulin (AIR Insulin) for diabetes, Exenatide LAR for Type 2 diabetes and AIR PTH for Osteoporosis. It enters into collaborations with pharmaceutical and biotechnology companies to develop new product candidates based on existing drugs incorporating its technologies.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 8
    Locations and Subsidiaries 11
    Company Financials 12
    Stock Market Performance 12
    P&L 15
    Balance Sheet 18
    Cash Flow 18
    Business Segment Performance 19
    Products & Services 22
    Marketed Products 22
    Pipeline Products 23
    Technologies 25
    AC Forecast Product Sales 26
    Competitors and Strategic Business Relationships 27
    Key Competitors 27
    Key Suppliers 27
    Key Clients 28
    Shareholding Structure 29
    Strategy 30
    Company View 30
    Corporate Strategy 31
    SWOT Analysis 32
    Overview 32
    Strengths 33
    Weaknesses 34
    Opportunities 35
    Threats 36
    Value Chain Analysis 37
    Overview 37
    Product Development 38
    Manufacturing 39
    Scorecard 40
    Overview 40
    Scorecard Analysis 41
    Key Employees 42
    List of Key Employees 42
    Key Employee Biographies 43
    Financial and Operational Overview 49
    Financial and Operational Overview 49
    APPENDIX 52
    Ask the analyst 52
    Datamonitor consulting 52
    Disclaimer 52


    TABLE OF FIGURES
    Figure 1: Alkermes - Operating Revenue/Cost Analysis, 2002-2007 ($ Mn) 16
    Figure 2: Alkermes - Key Strategic Revenues, 2003-2007 ($ Mn) 21


    TABLE OF TABLES
    Table 1: Alkermes - Key Facts 6
    Table 2: Alkermes – Locations and Subsidiaries 11
    Table 3: Alkermes - Year-End Share Price and Market Capitalization, 2002-2006 ($) 12
    Table 4: Alkermes - Key Events Impacting Share Price Performance 13
    Table 5: Alkermes - Operating Revenue/Cost Analysis, 2002-2007 ($ Mn) 15
    Table 6: Alkermes - Operating Cost Ratio Analysis, 2002-2007 (% of total revenues) 17
    Table 7: Alkermes - Balance Sheet, 2002-2006 ($ Mn) 18
    Table 8: Alkermes – Cash Flow, 2002-2006 ($ Mn) 18
    Table 9: Alkermes - Revenue Breakdown by Division, 2002-2007 ($ Mn) 19
    Table 10: Alkermes - Marketed Products 22
    Table 11: Alkermes - In-house Pipeline Products 23
    Table 12: Alkermes - Collaboration Products 23
    Table 13: Alkermes - Forecast Sales, 2006-2011 ($ Mn) 26
    Table 14: Alkermes - Key Competitors 27
    Table 15: Alkermes - Key Suppliers 28
    Table 16: Alkermes - Key Clients 28
    Table 17: Alkermes - Key Shareholders 29
    Table 18: Alkermes - SWOT Analysis Summary 32
    Table 19: Alkermes - Value Chain Analysis 38
    Table 20: Alkermes - Scorecard 40
    Table 21: Alkermes - Key Employees 42
    Table 22: Alkermes - Financial and Operational Overview 50